{"transactions":[{"id":3310526,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":152357,"kind":"person","name":"Oh Jeong Gyun","position":1,"cik":"0001794777","reported_name":"Oh Jeong Gyun","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2020-01-16T00:15:33.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments beginning on 2/13/2020, such that the option will be fully vested on the third anniversary of the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":8.39,"expiration_date":"2030-01-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001683168-20-000163","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000163/ownership.xml","form_type":"4"}},{"id":3326584,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":152357,"kind":"person","name":"Oh Jeong Gyun","position":1,"cik":"0001794777","reported_name":"Oh Jeong Gyun","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T02:53:09.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":240051,"ownership":{"direct":false,"nature":"Held by spouse."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the closing of the Merger in exchange for 210,000 shares of common stock of NeuroBo issued upon the conversion of Series B preferred stock of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by the spouse of Jeong Gyun Oh."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing of the Merger, each share of NeuroBo common stock was exchanged for 1.1431 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":240051,"source":{"system":"sec-edgar","filing":"0001683168-20-000015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000015/ownership.xml","form_type":"4"}},{"id":3326583,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":152357,"kind":"person","name":"Oh Jeong Gyun","position":1,"cik":"0001794777","reported_name":"Oh Jeong Gyun","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T02:53:09.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":1817842,"ownership":{"direct":false,"nature":"Held by JK BioPharma Solutions, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in connection with the closing of the merger of GR Merger Sub Inc., a wholly-owned subsidiary of the Issuer, with and into NeuroBo Therapeutics, Inc. (formerly NeuroBo Pharmaceuticals, Inc.) (\"NeuroBo\") on December 30, 2019, in exchange for (i) 1,000,000 shares of common stock of NeuroBo and (ii) 590,274 shares of common stock of NeuroBo issued upon conversion of convertible promissory notes of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by JK BioPharma Solutions, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing of the Merger, each share of NeuroBo common stock was exchanged for 1.1431 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Oh is the President and Chief Executive Officer of JK BioPharma Solutions, Inc., and as such has voting and investment control over the shares held by JK BioPharma Solutions, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1817842,"source":{"system":"sec-edgar","filing":"0001683168-20-000015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000015/ownership.xml","form_type":"4"}}]}